Irish Life Investment Managers’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Irish Life Investment Managers’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$246K	Buy	+3,713	New	+$212K	﹤0.01%	683

Other funds holding SLXP

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Irish Life Investment Managers's SLXP Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2013: 3,713 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #683 among its holdings.

243 funds tracked by Wall St. Rank hold SLXP as of Q2 2013.

Irish Life Investment Managers held 3,713 shares of SALIX PHARMACEUTICALS LTD DEL worth $246K as of Q2 2013.
SALIX PHARMACEUTICALS LTD DEL was a new Irish Life Investment Managers position in Q2 2013.
SALIX PHARMACEUTICALS LTD DEL made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #683 holding.
243 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.